Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A new page revision v3.5.4 is added, replacing the previous v3.5.3 revision. This indicates a minor metadata update to the study page rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-15T04:52:01.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, representing a minor version update to the page.
    Difference
    0.1%
    Check dated 2026-04-30T18:37:56.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision label was updated to Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:52:10.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added revision: v3.5.0; deleted revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:40.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 to reflect the page's latest version.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:23.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the funding-lapse notice has been removed. This update does not modify study content, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-11T09:24:37.000Z thumbnail image

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.